AMINOSOFT DROPS COMBINATION PRODUCT LIQUID

Indications

• Gastroesophageal reflux disease (GERD)
• Peptic ulcers
• Dyspepsia
• Acid-base balance disorders

Dosage

Children: Refer to specific acid formulations and guidelines for dosing. General dosing depends on the acid and its clinical use.

Adults: Refer to specific acid formulations and guidelines for dosing. General dosing depends on the acid and its clinical use.

Mechanism of action

Acids exert their effects primarily by dissociating into protons and anions in solution, thereby lowering the pH of the surrounding environment. This proton donation can influence various physiological processes, including enzyme activity, ion transport, and cellular signaling pathways. For example, hydrochloric acid in the stomach aids in digestion and the absorption of certain nutrients.

Pharmacodynamics

The pharmacodynamic effects of acids are largely dependent on their concentration and the specific type of acid involved. Weak acids may dissociate partially, leading to a less pronounced effect, while strong acids fully dissociate, leading to significant changes in pH and potential tissue irritation. Acids can also interact with various receptors and enzymes, influencing metabolic pathways and physiological responses.

Pharmacokinetics

The pharmacokinetics of acids vary widely depending on their chemical structure. Strong acids, such as hydrochloric acid, do not significantly enter systemic circulation due to their rapid dissociation in aqueous environments. Weak acids may be absorbed through the gastrointestinal tract, where their absorption is influenced by pH, solubility, and the presence of food. Metabolism and excretion pathways also vary, with some acids being metabolized to bicarbonate or other metabolites before excretion, primarily via the kidneys.

Adverse effects

• Gastrointestinal irritation
• Nausea
• Vomiting
• Abdominal pain
• Diarrhea
• Electrolyte imbalance

Precautions

• Use with caution in patients with renal impairment
• Monitor for signs of gastrointestinal bleeding
• Consider potential interactions with other medications that may affect gastrointestinal motility or pH levels

Pregnancy

The safety of various acids during pregnancy may vary; consult specific guidelines for each acid. Generally, use should be limited to essential cases.

Breast-feeding

Caution is advised when using acids during breastfeeding; consult specific guidelines for each acid.

Storage

Store in a cool, dry place away from direct sunlight. Keep tightly closed and out of reach of children.

Indications

• Asthma
• Chronic obstructive pulmonary disease (COPD)
• Bronchospasm associated with respiratory conditions

Dosage

Children: Refer to the BNF for Children for specific paediatric dosing guidelines.

Adults: Refer to the BNF for specific adult dosing guidelines.

Mechanism of action

Aminophylline works as a phosphodiesterase inhibitor, leading to an increase in intracellular cyclic AMP (cAMP). This action results in the relaxation of bronchial smooth muscle, bronchodilation, and reduced airway resistance. It may also exert anti-inflammatory effects by inhibiting the release of inflammatory mediators from mast cells.

Pharmacodynamics

The pharmacodynamics of aminophylline involve its ability to enhance respiratory function by decreasing airway resistance, improving mucociliary clearance, and increasing respiratory muscle strength. Its therapeutic effects typically begin within 30 minutes of administration, with a peak effect occurring within 2 hours.

Pharmacokinetics

Aminophylline is rapidly absorbed following intravenous administration, with a bioavailability of approximately 100%. Its volume of distribution is large, indicating extensive tissue binding. The drug is metabolized primarily in the liver via cytochrome P450 enzymes, with a half-life ranging from 3 to 10 hours depending on patient factors, including age, liver function, and concurrent medications.

Interactions

• aminoglycosides+agalsidasealfa: Severe (decreases effects)
• aminoglycosides+agalsidasebeta: Severe (decreases effects)
• betablockers,selective+aminophylline: Severe (increases risk of bronchospasm)
• aminophylline+phosphodiesterasetype-: Severe (increases exposure)
• stiripentol+aminophylline: Severe (increases exposure)
• deferasirox+aminophylline: Severe (increases exposure)
• aminophylline+roflumilast: Severe (increases exposure)
• aciclovir+aminophylline: Moderate (increases exposure)
• aminophylline+macrolides: Moderate (decreases exposure)
• aminophylline+erythromycin: Moderate (decreases exposure)

Indications

• Vitamin C deficiency
• Scurvy
• As an adjunct in the treatment of iron deficiency anemia
• Support for immune function
• Antioxidant therapy

Dosage

Adults: Refer to the BNF for specific

Mechanism of action

Ascorbic acid functions primarily as a reducing agent, donating electrons to various biochemical reactions. It is involved in the hydroxylation of proline and lysine residues in collagen synthesis, which is essential for maintaining connective tissue integrity. As an antioxidant, it also helps to regenerate other antioxidants, such as vitamin E, thereby protecting cells from oxidative damage. Furthermore, it enhances the absorption of non-heme iron from the gastrointestinal tract, promoting better iron utilization in the body.

Pharmacodynamics

Ascorbic acid is crucial for metabolic processes, including the synthesis of collagen and certain neurotransmitters. Its antioxidant properties help mitigate oxidative stress, which can lead to cellular damage and various diseases. The vitamin's role in iron absorption is particularly significant in preventing iron-deficiency anemia. The therapeutic effects of ascorbic acid are dose-dependent, with higher doses often resulting in more pronounced antioxidant effects.

Pharmacokinetics

Ascorbic acid is readily absorbed in the small intestine, with peak plasma concentrations occurring within 2 to 4 hours after oral administration. The bioavailability of ascorbic acid decreases at higher doses due to saturation of the transport mechanisms. It is distributed throughout bodily fluids and tissues, with highest concentrations found in the adrenal glands, pituitary gland, and leukocytes. The elimination half-life varies, typically ranging from 8 to 40 days, depending on the dose and the individual's renal function. Ascorbic acid is excreted primarily through the kidneys, with renal clearance being influenced by plasma concentration and renal health.

Interactions

• ascorbic acid + iron chelators: Unknown (increases risk of cardiovascular adverse effects)
• ascorbic acid + deferiprone: Unknown (increases risk of cardiovascular adverse effects)
• ascorbic acid + desferrioxamine: Unknown (increases risk of cardiovascular adverse effects)

Pregnancy

Ascorbic acid is generally considered safe during pregnancy but should be used with caution and only when necessary.

Breast-feeding

Ascorbic acid is excreted in breast milk and is generally considered safe during breastfeeding.

Storage

Store at room temperature, away from light and moisture.